Why Cryoablation Matters: Revolutionizing Patient Care

On-Demand Webinar
HCP Resources Page
image
Description
In this webinar, a panel of industry-leading GYNs and endometrial ablation experts explore how women’s health professionals can make heavy menstrual bleeding (HMB) care more patient-centered with new innovations in cryotherapy. The featured speakers will discuss the role of cryotherapy in changing the treatment paradigm for HMB, specifically how leveraging a new ablation technique can drive satisfactory and sustainable outcomes. Key Takeaways
  1. Optimizing Patient Selection for Ablation: The webinar provides an in-depth exploration into the first crucial step to successful endometrial ablation: evaluating key health and lifestyle considerations to ensure the right patients are selected for endometrial ablation.
  2. Prioritizing Safety and Patient Goals: The speakers explore how traditional heat-based techniques can interfere with patient goals and treatment expectations. Cerene® overcomes these challenges with cryotherapy to provide safe ablations, a tolerable treatment experience, and a convenient office-based procedure.
  3. Promoting Short- and Long-Term Outcomes: The webinar presents clinical research that supports Cerene as an effective cryotherapy device to not only achieve short-term HMB relief but also promote future health outcomes by resulting in minimal intrauterine scarring, maintaining hysteroscopic cavity access, and enabling comprehensive diagnostic evaluation.
Complete the Form Below to View
Now Playing
Video Library
GYN experts, Taraneh Shirazian, MD, Richard Salter, MD and Barbara Levy, MD, explore how women’s health professionals can make heavy menstrual bleeding care more patient-centered with new innovations in cryotherapy.
Barbara Levy, MD moderates a discussion with Geoffrey Bowers, MD and Leslie Hansen Lindner, MD on their insights on the evolution of endometrial ablation and how innovations in cryotherapy may reshape thinking around heavy menstrual bleeding treatment.
A compilation of physician perspectives on the treatment of heavy menstrual bleeding and the Cerene Cryotherapy Device. (4 minutes)
Barbara Levy, MD discusses the treatment of heavy menstrual bleeding and the Cerene Cryotherapy Device. (4 minutes)
James Greenberg, MD and Barbara Levy, MD discuss the implications from recent and historical publications on the rates of hysterectomy after an endometrial ablation.
James Coad, MD and Andrew Brill, MD discuss the science and benefits of cryotherapy for endometrial ablation.
Barbara Levy, MD and Todd Rumsey, MD discuss patient selection criteria for the Cerene Cryotherapy Device (27 minutes).
Barbara Levy, MD along with panelists Robert Rubino, MD, Richard Salter, MD, and Shannon Smith, MD provide insights into the management of menorrhagia. (59 minutes)
Barbara Levy, MD and Gerard Reilly, MD discuss how new innovations in cryotherapy are transforming the treatment of heavy menstrual bleeding. (45 minutes)

Important Safety Information

Cerene® Cryotherapy Device is indicated to ablate the endometrial lining of the uterus in premenopausal women with heavy menstrual bleeding due to benign causes for whom childbearing is complete. Pregnancy following the Cerene procedure can be dangerous; therefore, contraception must be used until menopause. The Cerene procedure is not for those who have or suspect uterine cancer; have an active genital, urinary or pelvic infection; or an IUD. As with all surgical procedures, there are risks and considerations associated with the use of the Cerene Cryotherapy Device. Temporary side effects may include cramping, nausea, vomiting, vaginal discharge and spotting. For detailed benefit and risk information, consult the Cerene Instructions for use (IFU) or your healthcare professional. Learn More